Common Contracts
5 similar Stock Option Agreement contracts by Dyne Therapeutics, Inc., Generation Bio Co., Inozyme Pharma, Inc., others
Xilio Therapeutics, Inc. Stock Option Agreement Granted Under 2020 Stock Incentive PlanStock Option Agreement • May 24th, 2021 • Xilio Therapeutics, Inc. • Pharmaceutical preparations
This Stock Option Agreement (this “Agreement”) is made between Xilio Therapeutics, Inc., a Delaware corporation (the “Company”), and the Participant pursuant to the 2020 Stock Incentive Plan (the “Plan”).
WEREWOLF THERAPEUTICS, INC. STOCK OPTION AGREEMENT GRANTED UNDER 2017 STOCK INCENTIVE PLANStock Option Agreement • February 26th, 2021 • Werewolf Therapeutics, Inc. • Pharmaceutical preparations
This Stock Option Agreement (this “Agreement”) is made between Werewolf Therapeutics, Inc., a Delaware corporation (the “Company”), and the Participant pursuant to the 2017 Stock Incentive Plan (the “Plan”).
DYNE THERAPEUTICS, INC. STOCK OPTION AGREEMENT GRANTED UNDER 2018 STOCK INCENTIVE PLANStock Option Agreement • August 25th, 2020 • Dyne Therapeutics, Inc. • Pharmaceutical preparations
This Stock Option Agreement (this “Agreement”) is made between Dyne Therapeutics, Inc., a Delaware corporation (the “Company”), and the Participant pursuant to the 2018 Stock Incentive Plan (the “Plan”).
INOZYME PHARMA, INC. STOCK OPTION AGREEMENT GRANTED UNDER AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLANStock Option Agreement • July 2nd, 2020 • Inozyme Pharma, Inc. • Pharmaceutical preparations
This Stock Option Agreement (this “Agreement”) is made between Inozyme Pharma, Inc., a Delaware corporation (the “Company”), and the Participant pursuant to the Amended and Restated 2017 Equity Incentive Plan (the “Plan”).
GENERATION BIO CO. STOCK OPTION AGREEMENT GRANTED UNDER 2017 STOCK INCENTIVE PLANStock Option Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations
This Stock Option Agreement (this “Agreement”) is made between Generation Bio Co., a Delaware corporation (the “Company”), and the Participant pursuant to the 2017 Stock Incentive Plan (the “Plan”).
